PhoenixBio Co.,Ltd. Logo

PhoenixBio Co.,Ltd.

A CRO providing humanized liver mouse models for preclinical drug studies.

6190 | T

Overview

Corporate Details

ISIN(s):
JP3803010002
LEI:
Country:
Japan
Address:
東広島市鏡山三丁目4番1号

Description

PhoenixBio is a contract research organization (CRO) specializing in translational animal models for the pharmaceutical industry. The company's core product is the PXB-mouse®, a proprietary chimeric mouse model featuring a liver that is highly repopulated (over 70%) with functional human hepatocytes. This humanized liver model is utilized globally in preclinical studies to evaluate drug metabolism, pharmacokinetics, and toxicity. In addition to supplying the PXB-mouse® and primary human hepatocytes (PXB-cells®), PhoenixBio provides comprehensive, quality-controlled contract study services to support drug discovery and early development projects.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-14 08:12
確認書
Japanese 8.1 KB
2025-11-14 08:10
半期報告書-第25期(2025/04/01-2026/03/31)
Japanese 163.4 KB
2025-07-01 04:29
臨時報告書
Japanese 22.2 KB
2025-06-25 04:07
内部統制報告書-第24期(2024/04/01-2025/03/31)
Japanese 22.3 KB
2025-06-25 04:04
確認書
Japanese 8.0 KB
2025-06-25 04:02
有価証券報告書-第24期(2024/04/01-2025/03/31)
Japanese 912.3 KB
2025-05-23 05:02
臨時報告書
Japanese 19.1 KB
2025-05-14 09:55
臨時報告書
Japanese 20.1 KB
2025-03-03 02:24
臨時報告書
Japanese 19.0 KB
2024-11-14 08:06
確認書
Japanese 8.0 KB
2024-11-14 08:04
半期報告書-第24期(2024/04/01-2025/03/31)
Japanese 165.5 KB
2024-07-02 02:35
臨時報告書
Japanese 18.4 KB
2024-07-01 07:59
臨時報告書
Japanese 21.4 KB
2024-06-27 03:06
内部統制報告書-第23期(2023/04/01-2024/03/31)
Japanese 22.1 KB
2024-06-27 03:04
確認書
Japanese 8.0 KB

Automate Your Workflow. Get a real-time feed of all PhoenixBio Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for PhoenixBio Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for PhoenixBio Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ProQR Therapeutics N.V. Logo
Develops RNA therapies for severe genetic disorders using its RNA editing platform.
United States of America
PRQR
Prostatype Genomics AB Logo
Develops a genetic test that assesses prostate cancer aggressiveness to guide treatment.
Sweden
PROGEN
Protagenic Therapeutics, Inc.\new Logo
Develops peptide-based therapeutics for stress-related neuropsychiatric disorders.
United States of America
PTIX
Protara Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapies for cancer and rare diseases.
United States of America
TARA
PROTEINA CO.,LTD. Logo
A biotech firm analyzing protein interactions for drug and diagnostic development.
South Korea
468530
PROTEOME SCIENCES PLC Logo
A Contract Research Organization focused on applied proteomics and peptidomics services.
United Kingdom
PRM
PROTHENA CORP PUBLIC LTD CO Logo
Biotechnology company developing therapies for diseases of protein dysregulation.
United States of America
PRTA
PROVEXIS PLC Logo
Develops and licenses functional ingredients for the food and supplement markets.
United Kingdom
PXS
Psomagen, Inc. Logo
A contract lab providing multiomics and data analysis solutions for researchers.
United States of America
950200
Psych Capital Plc Logo
Biopharmaceutical company developing psilocybin-based therapy for anorexia nervosa.
United Kingdom
PSY

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.